1,3-bis-[3,5-bis(benzylidene)-4-oxo-piperidin-1yl]propane

ID: ALA2391222

PubChem CID: 73352019

Max Phase: Preclinical

Molecular Formula: C41H38N2O2

Molecular Weight: 590.77

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1/C(=C\c2ccccc2)CN(CCCN2C/C(=C\c3ccccc3)C(=O)/C(=C/c3ccccc3)C2)C/C1=C\c1ccccc1

Standard InChI:  InChI=1S/C41H38N2O2/c44-40-36(24-32-14-5-1-6-15-32)28-42(29-37(40)25-33-16-7-2-8-17-33)22-13-23-43-30-38(26-34-18-9-3-10-19-34)41(45)39(31-43)27-35-20-11-4-12-21-35/h1-12,14-21,24-27H,13,22-23,28-31H2/b36-24-,37-25+,38-26+,39-27+

Standard InChI Key:  GSYUJGOKPBKKJT-NOVHRWNDSA-N

Molfile:  

     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
   14.7873  -11.0600    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7850  -11.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4930  -12.2877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2032  -11.8811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2055  -11.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4975  -10.6533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9112  -12.2916    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9123  -10.6569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6171  -11.0593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3214  -10.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0352  -11.0428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0447  -11.8599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3404  -12.2767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6266  -11.8764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4907  -13.1049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7736  -13.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0704  -13.0921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3576  -13.4942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3502  -14.3090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0534  -14.7252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7641  -14.3266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3934   -9.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4022   -8.5978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1156   -8.1969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1265   -7.3786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4240   -6.9612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7105   -7.3621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6996   -8.1805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4349   -6.1429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0080   -6.9448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2945   -7.3457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5920   -6.9283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8806   -7.3257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8697   -8.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5723   -8.5614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2857   -8.1605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8400   -6.9777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5465   -7.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5600   -8.1894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2748   -8.5880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9760   -8.1683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9624   -7.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2476   -6.9514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0965   -9.8291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0873  -10.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  4  7  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
  5  8  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 16 21  2  0
  3 15  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 23 28  1  0
 26 29  2  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 31 36  2  0
 27 30  2  0
 37 38  1  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 38 43  2  0
 25 37  2  0
 22 23  1  0
 22 44  1  0
 44 45  1  0
 45  1  1  0
M  END

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC 2998 (41480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW-620 (52400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60(TB) (4309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ramos (1218 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJAB (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YT (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC70 (557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LAPC4 (305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HS27 (243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EL4 (235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 590.77Molecular Weight (Monoisotopic): 590.2933AlogP: 7.48#Rotatable Bonds: 8
Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 5.43CX LogP: 8.45CX LogD: 8.45
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.20Np Likeness Score: -0.27

References

1. Das S, Das U, Michel D, Gorecki DK, Dimmock JR..  (2013)  Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.,  64  [PMID:23644215] [10.1016/j.ejmech.2013.03.055]
2. Santiago-Vazquez Y, Das S, Das U, Robles-Escajeda E, Ortega NM, Lema C, Varela-Ramírez A, Aguilera RJ, Balzarini J, De Clercq E, Dimmock SG, Gorecki DK, Dimmock JR..  (2014)  Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.,  77  [PMID:24657568] [10.1016/j.ejmech.2014.03.009]

Source